Consolidated Statements of Changes in Equity - USD ($) |
Ordinary Shares
Class A
|
Ordinary Shares
Class B
|
Additional Paid-in Capital |
Deferred Share Compensation |
Statutory Reserve |
Accumulated Deficit |
Accumulated Other Comprehensive Income (Loss) |
Noncontrolling Interest |
Total |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance at Dec. 31, 2022 | $ 2,054 | $ 550 | $ 24,998,388 | $ 1,315,017 | $ 4,124,037 | $ (511,824) | $ 3,091,043 | $ 33,019,265 | |||
| Balance (in Shares) at Dec. 31, 2022 | [1] | 256,643 | 68,722 | ||||||||
| Share-based compensation expenses | $ 2 | 135,545 | 135,547 | ||||||||
| Share-based compensation expenses (in Shares) | [1] | 225 | |||||||||
| Net (loss) income | (11,335,911) | 28,672 | (11,307,239) | ||||||||
| Appropriation of statutory reserve | 56,151 | (56,151) | |||||||||
| Foreign currency translation adjustments | (721,077) | (88,326) | (809,403) | ||||||||
| Balance at Dec. 31, 2023 | $ 2,056 | $ 550 | 25,133,933 | 1,371,168 | (7,268,025) | (1,232,901) | 3,031,389 | 21,038,170 | |||
| Balance (in Shares) at Dec. 31, 2023 | [1] | 256,868 | 68,722 | ||||||||
| Sales of ordinary shares | $ 13,094 | 3,825,106 | 3,838,200 | ||||||||
| Sales of ordinary shares (in Shares) | [1] | 1,636,750 | |||||||||
| Exercise of warrants | $ 9,600 | (9,600) | |||||||||
| Exercise of warrants (in Shares) | [1] | 1,200,000 | |||||||||
| Issuance of ordinary shares for compensation | $ 39 | 109,675 | 109,714 | ||||||||
| Issuance of ordinary shares for compensation (in Shares) | [1] | 4,875 | |||||||||
| Issuance of fraction shares for share consolidation | $ 51 | (51) | |||||||||
| Issuance of fraction shares for share consolidation (in Shares) | [1] | 6,398 | |||||||||
| Reversal of statutory reserve | (113,186) | 113,186 | |||||||||
| Net (loss) income | (643,229) | 369,816 | (273,413) | ||||||||
| Appropriation of statutory reserve | 161,208 | (161,208) | |||||||||
| Foreign currency translation adjustments | (473,559) | (88,059) | (561,618) | ||||||||
| Balance at Dec. 31, 2024 | $ 24,840 | $ 550 | 29,059,063 | 1,419,190 | (7,959,276) | (1,706,460) | 3,313,146 | 24,151,053 | |||
| Balance (in Shares) at Dec. 31, 2024 | [1] | 3,104,891 | 68,722 | ||||||||
| Reversal of statutory reserve | (141,513) | 141,513 | |||||||||
| Share-based compensation expenses | $ 1,050 | $ 4,450 | 5,416,503 | (1,716,667) | 3,705,336 | ||||||
| Share-based compensation expenses (in Shares) | [1] | 131,250 | 556,250 | ||||||||
| Net (loss) income | (6,310,153) | 495,286 | (5,814,867) | ||||||||
| Appropriation of statutory reserve | 62,654 | (62,654) | |||||||||
| Foreign currency translation adjustments | 397,596 | 158,838 | 556,434 | ||||||||
| Balance at Dec. 31, 2025 | $ 25,890 | $ 5,000 | $ 34,475,566 | $ (1,716,667) | $ 1,340,331 | $ (14,190,570) | $ (1,308,864) | $ 3,967,270 | $ 22,597,956 | ||
| Balance (in Shares) at Dec. 31, 2025 | [1] | 3,236,141 | 624,972 | ||||||||
| |||||||||||
| X | ||||||||||
- Definition Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of shares issued which are neither cancelled nor held in the treasury. No definition available.
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of share options (or share units) exercised during the current period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Value of stock issued as a result of the exercise of stock options. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Represents amount of appropriation of statutory reserve. No definition available.
|
| X | ||||||||||
- Definition Issuance of fraction shares for share consolidation. No definition available.
|
| X | ||||||||||
- Definition Number of shares of stock issued attributable to transactions classified as Sale of ordinary shares. No definition available.
|
| X | ||||||||||
- Definition Stock issued during period, value issuance of fraction shares for share consolidation. No definition available.
|
| X | ||||||||||
- Definition Reversal of statutory reserve. No definition available.
|
| X | ||||||||||
- Definition Value of shares of stock issued attributable to transactions classified as sale of ordinary share. No definition available.
|